{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-054461","form_type":"8-K","ticker":"BRRN","cik":"0001397795","company_name":"Byrn, Inc.","filed_at":"2026-05-11T20:01:31+00:00","discovered_at":"2026-05-11T20:04:03.457037+00:00","generated_at":"2026-05-15T02:23:57.304671+00:00","sec_items":["5.01","5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bryn Inc. undergoes change in control; MEDO Healthcare acquires 84.7% voting power, new CEO appointed","bullets":["On April 24, 2026, MEDO Healthcare LLC purchased 10M shares of Series A-1 Preferred Stock for $175,000 cash, gaining 84.7% voting power.","David Lazar resigned as sole officer/director; John Leo appointed as sole director and CEO, Arthur Magee as CFO and Secretary.","John Leo holds 27.4% membership interest in MEDO Healthcare and also owns Primary Capital LLC.","New management team has extensive investment banking and capital markets experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054461","json":"https://secwatch.observer/filing/0001213900-26-054461.json","markdown":"https://secwatch.observer/filing/0001213900-26-054461.md","text":"https://secwatch.observer/filing/0001213900-26-054461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/0001213900-26-054461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/ea0289997-8k_bryninc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:23:57.304671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3800407b32","claim":"David Lazar resigned as Sole Officer and Director at Byrn, Inc..","evidence_excerpt":"Mr. Lazar resigned on April 24, 2026 from his positions as sole officer and director of the Registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/0001213900-26-054461-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Sole Officer and Director"}],"fact_type":"executive_change"},{"claim_id":"42f898bd87","claim":"Arthur Magee was appointed as Chief Financial Officer and Secretary at Byrn, Inc..","evidence_excerpt":"Mr. Lazar also appointed Arthur Magee, an affiliate of John Leo, to serve upon Mr. Lazar’s resignation as CFO and Secretary of the Registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/0001213900-26-054461-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"8716e2f2e9","claim":"John Leo was appointed as Sole Director and Chief Executive Officer at Byrn, Inc..","evidence_excerpt":"Mr. Lazar appointed John Leo to serve upon Mr. Lazar’s resignation as sole director and CEO of the Registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1397795/000121390026054461/0001213900-26-054461-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Sole Director and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}